U.S. markets open in 3 hours 48 minutes
  • S&P Futures

    4,253.00
    +21.50 (+0.51%)
     
  • Dow Futures

    33,942.00
    +183.00 (+0.54%)
     
  • Nasdaq Futures

    14,353.00
    +90.00 (+0.63%)
     
  • Russell 2000 Futures

    2,314.70
    +14.40 (+0.63%)
     
  • Crude Oil

    73.18
    +0.10 (+0.14%)
     
  • Gold

    1,780.70
    -2.70 (-0.15%)
     
  • Silver

    26.05
    -0.07 (-0.25%)
     
  • EUR/USD

    1.1943
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    15.58
    -1.08 (-6.48%)
     
  • GBP/USD

    1.3956
    -0.0007 (-0.05%)
     
  • USD/JPY

    110.8600
    -0.1020 (-0.09%)
     
  • BTC-USD

    33,506.24
    -507.87 (-1.49%)
     
  • CMC Crypto 200

    810.02
    -0.18 (-0.02%)
     
  • FTSE 100

    7,090.76
    +16.70 (+0.24%)
     
  • Nikkei 225

    28,875.23
    +0.34 (+0.00%)
     

Norway should exclude J&J, AstraZeneca from COVID vaccination scheme, says commission

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

OSLO, May 10 (Reuters) - Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson in its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday.

Those who would volunteer to take either of the two vaccines should however be allowed to do so, the commission added.

Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

On April 15, the Norwegian Institute of Public Health said the AstraZeneca vaccine should be dropped entirely but the government instead sought further advice, including on the jabs made by J&J which the country has yet to adopt. (Reporting by Terje Solsvik, editing by Gwladys Fouche)